Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirt, Penelope, Park, Lily, Wallace, Carly E., Kerdel, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582651/
https://www.ncbi.nlm.nih.gov/pubmed/37860722
http://dx.doi.org/10.4081/dr.2023.9668
_version_ 1785122378584424448
author Hirt, Penelope
Park, Lily
Wallace, Carly E.
Kerdel, Francisco
author_facet Hirt, Penelope
Park, Lily
Wallace, Carly E.
Kerdel, Francisco
author_sort Hirt, Penelope
collection PubMed
description Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine.
format Online
Article
Text
id pubmed-10582651
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-105826512023-10-19 Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine Hirt, Penelope Park, Lily Wallace, Carly E. Kerdel, Francisco Dermatol Reports Case Report Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine. PAGEPress Publications, Pavia, Italy 2023-05-23 /pmc/articles/PMC10582651/ /pubmed/37860722 http://dx.doi.org/10.4081/dr.2023.9668 Text en Copyright © 2023, the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Case Report
Hirt, Penelope
Park, Lily
Wallace, Carly E.
Kerdel, Francisco
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title_full Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title_fullStr Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title_full_unstemmed Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title_short Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
title_sort recurrent giant cellulitis-like sweet syndrome induced by sars-cov-2 pfizer-biontech mrna vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582651/
https://www.ncbi.nlm.nih.gov/pubmed/37860722
http://dx.doi.org/10.4081/dr.2023.9668
work_keys_str_mv AT hirtpenelope recurrentgiantcellulitislikesweetsyndromeinducedbysarscov2pfizerbiontechmrnavaccine
AT parklily recurrentgiantcellulitislikesweetsyndromeinducedbysarscov2pfizerbiontechmrnavaccine
AT wallacecarlye recurrentgiantcellulitislikesweetsyndromeinducedbysarscov2pfizerbiontechmrnavaccine
AT kerdelfrancisco recurrentgiantcellulitislikesweetsyndromeinducedbysarscov2pfizerbiontechmrnavaccine

Ejemplares similares